Introduction 60
Mold cheese, fermented by multispecies microbial communities (Bertuzzi et al, 2018; Zhang et al, 2018) , has 61 been a traditional high-fat dairy product with the unsolved problem of low essential fatty acid (EFA) levels among 62 lipids . The polyunsaturated fatty acids (PUFA) content in raw milk is relatively low in mold cheese, and its EFA level 63 accounts for only 3.5% of total fatty acids (Hageman et al, 2019) . In addition, most of the predominant fungal strains 64 used to ferment this cheese do not have the ability to convert saturated fatty acids into many PUFAs or their 65 conversion rate is low. Delta 12 fatty acid desaturase (FADS12) plays a key role in the synthesis of EFAs during 66 fermentation. FADS12 is a key membrane-bound desaturase that converts oleic acid [OA, 18:1 Δ9 ] to linoleic acid [LA, 67 18:2 Δ9, 12 ] by introducing a double bond between carbons 12 and 13 in the carboxyl end of the substrate in the 68 biosynthesis of EFAs (Cui et al, 2016; Lee, 2016; Rodríguez-Rodríguez, 2016) . As a rate-limiting enzyme, FADS12 69 plays an important role in the metabolism of PUFAs, and its activity directly affects the level and distribution of EFAs 70 in cheese. 71 FADS12 has been studied as an important desaturase in fatty acid transformation for many years, with 72 experiments based on gene cloning, heterologous expression, and analysis of its catalytic mechanism (Brandstetter & 73 Ruther, 2016; Kaye et al, 2015; Kazuhiro et al, 2004; Kikukawa et al, 2013; Lamers et al, 2019; Rodríguez-Rodríguez, 74 2016; Sakamoto et al, 2017; ShanlinYu et al, 2008; Sun et al, 2016; Watanabe et al, 2004) . These studies were mostly 75 focused on the preparation of PUFAs, the regulation of the proportion of omega-3/omega-6 fatty acids and 76 heterologous expression from EFAs, which could not be synthesized in the human body (Wang et al, 2016; Yan et al, 77 2013; Zhang et al, 2013; Zhang et al, 2017) . However, heterologous expression of FADS12 in different host cells often 78 resulted in significant changes in its activity, which has made it difficult to screen for FADS12 with high activity in a 79 target strain. Therefore, it is important to study differences in the mechanisms underlying differential FADS12 activity 80 in various species. At present, research on the catalytic mechanism of fatty acid desaturase is still in its infancy (Lee et 81 al, 2016) , except that the three-dimensional structure of FADS9 was analyzed and found to be mushroom-shaped (Bai, 82 2015; Wang, 2015) and the molecular mechanisms underlying FADS2 substrate specificity (Shi et al, 2015) and 83 4 catalytic activity (Shi et al, 2018a) were analyzed in our previous study. However, studies on fatty acid desaturase in 84 dominant strains of cheese have not yet been undertaken. Previously, our laboratory identified the FADS12 gene in a 85
Geotrichum candidum (G. candidum) genome sequence submitted to the GenBank database (LOCUS: 86 CCBN010000001) by Casaregola, S. The function of this gene has been verified by the addition of substrates in vitro, 87 and, although the conversion rate of the enzyme encoded by this gene has been determined, its ability to transform OA 88 and LA substrates was found to be low (Luo et al, 2019) . 89
In studies focusing on the catalytic mechanism of membrane-bound enzyme function, reciprocal domain 90 swapping has commonly been used to locate regions or sites that affect activity (Aranko et al, 2013; Gammons et al, 91 2016; Haywood et al, 2018; Liu et al, 2012; Marcin et al, 2015; Meesapyodsuk & Qiu, 2014; Park et al, 2010; Qin et al, 92 2016; Sun et al, 2017; Vendome et al, 2011) . We also used this method in the previous study of FADS2 to locate the 93 domains and sites of FADS2 activity, but the conversion rates of recombinant FADS2s could not reach that of the 94 wild-type. Therefore, we wondered whether there were any components (Bichi et al, 2012; Chen et al, 2016; Pedrono 95 et al, 2018; Ralston et al, 2014 ) that hindered the synthesis of unsaturated fatty acids. R. Jeffcoat and M. R. Pollard 96 (Jeffcoat & Pollard, 1977) pointed out in 1977 that there was an accumulation of stearic acid 97 [8-(2-octyl-l-cyclopropenyl) octanoic acid, a C18 cyclopropenoid fatty acid] and apparent loss of OA in both tissues 98 and lipids in cows' milk. They showed that cyclopropenoid acid was an inhibitor of fatty acid desaturase. This is a 99 structural analogue of other fatty acids such as 12,13-cyclopropenoid fatty acid, which might also inhibit the activity 100 of FADS12 and prevent the conversion of OA to LA. If so, this could help to explain the low FADS12 activity in G. 101 candidum (Luo et al, 2019) and provided a new clue to study the catalytic mechanism of fatty acid desaturase. 102
In the present study, key domains and amino acid sites for FADS12 catalytic activity were located by domain 103 6 overlap extension PCR using the primers listed in Supplemental Table S1 and the PCR protocol described previously 132 (Shi et al, 2015) . The hybrid genes were ligated into the pPICZαA plasmid and transformed into competent Top10 133
cells. 134
In sections 3, 5, and 9-1, 18 mutants of the MaFADS12 gene were constructed, with amino acids substituted with 135 the corresponding residues in the GcFADS12 gene (H112K, Q117G, S118A, H156N, M157L, T158Q, K159R, Q161M 136 T298S, K301T, R306D, E307I, G308T, A309E, Q313A, L317A/C318A, V320I and S323D). Then, 18 corresponding 137 mutants of the GcFADS12 gene were constructed with reciprocal amino acids from the MaFADS12 gene (K123H, 138 G128Q, A129S, N167H, L168M, Q169T, R170K, M172Q, S299T, T302K, D307R, I308E, T309G, E310A, A314Q, 139 A318L/A319C, I321V and D324S). Mutation primers are listed in Supplemental Table S1 . 140
Each chimeric and wild-type desaturase gene was induced by 0.5 mM cis-OA at 28°C for 12 h under previously 141 described conditions (Shi et al, 2018a) . Then, the expression level of each chimeric desaturase in Pichia pastoris was 142 determined by western blotting analysis as described previously (Shi et al, 2015) ; each sample loading volume was 143 adjusted to the same level according to the western blot results to determine desaturase activity of each chimera. 144
Chimeric desaturase activity were analyzed by gas chromatography (GC) as described previously (Shi et al, 2016; Shi 145 et al, 2018b) . 146
Feedback inhibition of LA and its analogues 147
To examine FADS12 inhibition, 0.00 mM, 0.05 mM, 0.10 mM, 0.15 mM, 0.20 mM, 0.25 mM, 0.30 mM, 0.35 148 mM, 0.40 mM, 0.45 mM and 0.50 mM of 12,13-cyclopropenoid fatty acid was selected as the product analogue to add 149 to the culture medium with 0.5 mM cis-OA. LA, in concentrations corresponding to those of 12,13-cyclopropenoid 150 fatty acid, was selected to verify feedback inhibition of FADS12. Meanwhile, the conversion rates of chimera G3, G5, 151 G9, G3/5/9-1, chimera M3, M5, M9, and M3/5/9-1 were determined at various concentrations of 152 12,13-cyclopropenoid fatty acid. 153
Allosteric domain swapping between chimera M3/5/9-1 and chimera G3/5/9-1 154
To identify which allosteric domains are functionally involved in the catalytic activities of MaFADS12 and 155 7 GcFADS12, the corresponding sections 1, 2, 4, 6, 7, 8, and 9-2/3 in chimeras M3/5/9-1 and G3/5/9-1 were 156 systematically exchanged to construct recombinant swap genes that were generated by overlap extension PCR. In 157 sections 1 and 9-2/3, 26 mutants derived from the chimeric M3/5/9-1 gene were constructed, in which amino acids 158 were substituted with the corresponding residues in the chimeric G3/5/9-1 gene (Q34V, L35V, E37Q, R44L, E45D,  159   C46A, H50E, F52Y, E53K, G56Y, L57V, R58K, G59S, L60F, G334D, V336I, H337E, A341L, L344F, F345V, Q347R,  160 G10F, Q13Y, S24Y, K326F and L344F). Then, 28 corresponding mutants derived from the chimeric G3/5/9-1 gene 161 were constructed, in which amino acids were substituted with the corresponding residues in the chimeric M3/5/9-1 162 gene (V44Q, V45L, Q47E, L54R, D55E, A56C, E60H, Y62F, K63E, Y66G, V67L, K68R, S69G, F70L, D335G, I337V, 163 E338H, L342A, F345L, V346F, R348Q, Y4A, F20G, Y23Q, Y34S, F327K, F345L and F398A). Mutation primers are 164 listed in Supplemental Table S1 . 165
Determination of chimeric FADS12 properties 166
Chimera M3/5/9-1, chimera G3/5/9-1, chimera Al M1/9-2/3, chimera Al G1/9-2/3, MaFADS12, and GcFADS12 167 were selected to determine catalytic properties, including induction temperatures (18°C, 23°C, 28°C, 33°C, and 38°C 168 at pH 7.0 with a 12-h induction), pH (6.0, 6.5, 7.0, 7.5, and 8.0 at 28°C with a 12 h induction), and induction times (4 169 h, 8 h, 12 h, 16 h, 20 h, and 24 h at pH 7.0 and 28°C). 170
Molecular docking of fatty acids on the binding site of FADS12 171
The Discovery Studio 4.3 program (Accelrys Inc., San Diego, CA, USA) was used to optimize FADS12 by 172 adding hydrogen atoms and removing water molecules, and the Molegro. Docker 4.0 program (Molegro ApS, Aarhus, 173
Denmark) was used to prepare the FADS12 structure for docking calculations. 174
Results 175
Locating key domains and amino acid sites associated with FADS12 catalytic activity 176
Based on a multiple sequence alignment of the FADS12s and their C18:1 catalysis efficiencies (Fig. S1) , 177
MaFADS12 with highest catalytic activity and GcFADS12 with lowest catalytic activity were selected for domain 178 swapping. The results of domain swapping showed that the catalytic efficiencies of chimera M3 (MaFADS12 179 8 aa111-120 replaced by GcFADS12 aa122-131), chimera , and chimera M9 (MaFADS12 aa295-400 replaced by GcFADS12 aa296-412) were 12.6 ± 0.7%, 15.9 ± 181 0.6%, and 11.3 ± 1.6% respectively, much lower than those of wild-type MaFADS12 (87.6 ± 0.6%). Conversely, 182
whereas GcFADS12 exhibited a catalytic efficiency of 20.4 ± 1.0%, those of chimera G3 (GcFADS12 aa122-131 183 replaced by MaFADS12 aa111-120), chimera G5 (GcFADS12 aa161-197 replaced by MaFADS12 aa150-190), and 184 chimera G9 (GcFADS12 aa296-412 replaced by MaFADS12 aa295-400) were increased to 44.3 ± 0.5%, 28.2 ± 0.5%, 185 and 46.5 ± 4.0%, respectively (Figure 1) . Furthermore, section 9 was divided into three 'second-level' sections to 186
identify key functional areas that were then systematically exchanged between MaFADS12 and GcFADS12. The results 187 of an analysis of the second-level chimeras showed that the catalytic efficiency of chimera M9-1 (aa295-325 in 188
MaFADS12 replaced by aa296-326 in GcFADS12) was decreased to 5.6 ± 1.9%, compared to that exhibited by 189
MaFADS12 (Figure 1) . Likewise, replacement of aa296-326 (section 9-1) of GcFADS12 with aa295-325 of 190
MaFADS12 resulted in significantly increased (36.6 ± 1.0%) catalytic efficiency (Figure 1) . Replacement of the other 191 two second-level sections (sections 9-2 and 9-3) had no significant impact on the catalytic efficiency of FADS12. Key 192 functional areas, namely sections 3, 5, and 9-1, were exchanged simultaneously between MaFADS12 and GcFADS12, 193 and our results showed that the catalytic efficiency of chimera M3/5/9-1 decreased to 5.6 ± 0.6%, whereas that of 194 chimera G3/5/9-1 reached 56.3 ± 2.3%, exhibiting either lower or higher efficiencies than those of the other 195 corresponding section (i.e., the catalytic efficiencies of chimeras M3, 5, and 9-1 in MaFADS12 were lower than those 196 of chimeras G3, 5, and 9-1 in GcFADS12). 197
To further identify key amino acid sites associated with FADS12 catalytic activity, a series of constructs with 198 mutations in sections 3, 5, and 9-1 were generated (Figure 2) . Conversion efficiencies of these constructs were shown 199 to be greatly reduced in single mutants H112K, S118A, H156N, and Q161M to a rate of 23.6 ± 1.6 %, 25.6 ± 2.5 %, 200 20.9 ± 3.9 %, and 22.6 ± 2.1 %, respectively, for MaFADS12 with mutant sections 3 and 5 (Figure 2) . Conversely, 201 catalytic efficiencies were significantly enhanced in single mutants K123H, A129S, N167H, and M172Q (35.2 ± 1.3 %, 202 43.0 ± 2.1 %, 32.6 ± 3.5 %, and 36.3 ± 2.7 %, respectively, for GcFADS12 with mutant sections 3 and 5) (Figure 2) . 203 9 The conversion efficiencies of the section 9-1 MaFADS12 mutants K301T, R306D, E307I, A309E, and S323D and the 204 corresponding GcFADS12 mutants T302K, D307R, I308E, E310A, and D324S showed significant differences from 205 those of wild-type FADS12 (Figure 2) . Targeted mutagenesis of other points within sections 3, 5 and 9-1 did not 206 induce any major changes in FADS12 catalytic activity. 207
Inhibition of FADS12 catalytic activity by 12,13-cyclopropenoid fatty acid 208
To explain why the increase in activity of chimeras with key regions and sites described above was not significant, 209
we considered that there may be reaction components that inhibited activity of the enzyme. Therefore, we explored 210 feedback inhibition. By adding LA or 12,13-cyclopropenoid fatty acid (an LA analogue) as suspected inhibitors of 211 enzyme activity or a control (with neither fatty acid), we showed that both LA and 12,13-cyclopropenoid fatty acid 212 inhibited FADS12 activity (Figure 3a, b, c) . This result was confirmed by the effect of LA or 12,13-cyclopropenoid 213 fatty acid on GcFADS12 activity at a low concentration of LA or 12,13-cyclopropenoid fatty acid with substrate in the 214 medium. MaFADS12 activity did not significantly change when OA and 12,13-cyclopropenoid fatty acid or OA and 215 LA were added, whereas GcFADS12 activity decreased with an increase in 12,13-cyclopropenoid fatty acid or LA. 216
When the concentration of 12,13-cyclopropenoid fatty acid or LA reached 0.5 mM, GcFADS12 activity decreased 217 from 20.4 % to less than 3 %, which confirmed that these compounds strongly inhibit GcFADS12. 218
Moreover, the effects of 12,13-cyclopropenoid fatty acid on the activity of chimeras G3, G5, G9, G3/5/9-1, M3, 219 M5, M9, and M3/5/9-1 (shown by domain swapping) were analyzed. Our results showed that activities of four 220
GcFADS12 mutant enzymes, namely chimeras G3, G5, G9, and G3/5/9-1) decreased to half that of GcFADS12 at a 221 concentration as low as 0.05 mM of 12,13-cyclopropenoid fatty acid. With an increase in concentration, the activity of 222 these chimeras showed a slight decline (Figure 3d ). This confirmed that 12,13-cyclopropenoid fatty acid affected the 223 activities of these four chimeras, and that the concentration of LA or 12,13-cyclopropenoid fatty acid was not the real 224 reason for the change in enzyme activities. However, the activities of the four chimeras from MaFADS12 (chimeras 225 M3, M5, M9, and M3/5/9-1) remained unchanged in the presence of 12,13-cyclopropenoid fatty acid at various 226 concentrations (Figure 3e) . These results indicated that there may be "sensitive" regions for 12,13-cyclopropenoid 227 10 fatty acid or LA in the structure of GcFADS12 ("sensitive" regions, meaning regions that were changed by the product 228 and that affected binding between GcFADS12 and the substrate), and that 12,13-cyclopropenoid fatty acid does not 229 change the corresponding binding regions in MaFADS12. 230
Allosteric domains and amino acid sites also affect FADS12 catalytic activity 231
To explain the effects of 12,13-cyclopropenoid fatty acid and LA on GcFADS12 activity, we speculated that the 232 product changed the structure outside the active domains of GcFADS12, whereas the product did not change or 233 changed only to a small extent the corresponding region in MaFADS12. To locate allosteric domains, we swapped 234 domains other than those with localized active regions (i.e., chimeras 1, 2, 4, 6, 7, 8, and 9-2/3). The results showed 235 that the rates of conversion to OA by chimeras Al M1 and Al G1 derived from section 1 of MaFADS12 and GcFADS12 236 were 0.5 ± 0.2% (10 times lower than that of chimera M3/5/9-1) and 75.2 ± 0.3% (about 20% higher than that of 237 chimera G3/5/9-1), respectively (Figure 4a ). In addition, the rates of conversion to OA chimeras Al M9-2/3 and Al 238 G9-2/3 derived from section 9-2/3 of MaFADS12 and GcFADS12 were 0.3 ± 0.1% (22 times lower than that of 239 chimera M3/5/9-1) and 73.3 ± 3.5% (about 18% higher than that of chimera G3/5/9-1) (Figure 4a ). This result 240 suggested that there were two regions in MaFADS12, section 1 and section 9-2/3 that housed allosteric domains. 241
Moreover, the conversion rates of chimeras Al M1/9-2/3 and Al G1/9-2/3, which included the section 1 and 9-2/3 242 domains of MaFADS12 and GcFADS12, respectively, were 0.1 ± 0.0% and 80.7 ± 5.6%, which were higher than those 243 observed with single domain swapping (Figure 4a ). This confirmed that these two regions were the root cause of 244 feedback inhibition. 245
To further define key sites of feedback inhibition in the two regions, we first selected sites near conserved regions 246 in the allosteric domain for site-directed mutagenesis swaps in MaFADS12 and GcFADS12. Our results showed that 247 the conversion rates of mutants G56Y and L60F with section 1 from MaFADS12 were reduced to 0.4 ± 0.1% and 1.3 ± 248 0.2%, respectively, whereas the conversion rates of the corresponding mutants Y66G and F70L with section 1 from 249
GcFADS12 increased to 79.0 ± 4.1% and 75.0 ± 2.5%, respectively (Figure 4b) . In addition, the conversion rates of 250 mutant L344F with section 9-2/3 from MaFADS12 and the corresponding F345L mutant with section 9-2/3 from 251 11 GcFADS12 significantly changed, reaching 0.9 ± 0.2% and 71.2 ± 0.5%, respectively (Figure 4b) . 252
Based on the results of this site-directed mutagenesis swap, tyrosine and phenylalanine, aromatic amino acids 253 with a benzene ring structure, were implicated in FADS12 catabolism. We inferred that amino acids with large steric 254 hindrances such as benzene rings had a greater impact on product feedback inhibition. Subsequently, other aromatic 255 amino acids in sections 1 and 9-2/3 of GcFADS12 were selected for exchange with corresponding sites in MaFADS12. 256
Our results showed that the conversion rates of all MaFADS12 mutants, including G10F, Q13Y, S24Y, K326F, and 257 L344F, were reduced by an order of magnitude compared with those of chimera M3/5/9-1 (0.8 ± 0.2%, 0.8 ± 0.3%, 0.6 258 ± 0.2%, 0.4 ± 0.2%, and 0.3 ± 0.2%, respectively), whereas the conversion rates of Y4A, F398A, and corresponding 259 mutants from GcFADS12, namely F20G, Y23Q, Y34S, F327K, and F345L, increased by about 20% compared with 260 those of chimera G3/5/9-1, reaching 78.2 ± 2.5%, 72.2 ± 2.1%, 71.2 ± 2.0%, 77.2 ± 1.5%, 78.9 ± 2.5%, 75.2 ± 1.2%, 261 and 76.2 ± 1.5%, respectively (Figure 4c ). This result indicated that the aromatic amino acids in sections 1 and 9-2/3 262 of GcFADS12 caused feedback inhibition that affected the catalytic activity of FADS12. 263
Key allosteric and active domains with FADS12-stabilizing properties 264
Based on these results, we determined that there are both active and allosteric regions in MaFADS12 that are 265 associated with high catalytic activity, and that product feedback inhibition was weak with this enzyme because there 266 were no aromatic amino acids in the allosteric region so there was little steric hindrance. To determine whether this 267 conclusion was valid under different conditions, the conversion rates of MaFADS12, GcFADS12, and their 268 recombinant enzymes at various induction temperatures, pH, and times were determined. Our results showed that the 269 conversion rates of MaFADS12, chimera M3/5/9-1, and chimera Al G1/9-2/3 did not change significantly at different 270 induction temperatures, whereas those of GcFADS12, chimera G3/5/9-1, and chimera Al M1/9-2/3 fluctuated with 271 temperature (Figure 5a) . The same conclusion can be drawn about substrate conversion efficiencies at various pH and 272 induction times (Figure 5b, c) . From this result, it is apparent that the conversion efficiencies of FADS12s containing 273 allosteric regions (i.e., MaFADS12, chimera M3/5/9-1, and chimera Al G1/9-2/3) were not influenced by induction 274 temperature, pH, or time, but for FADS12s without allosteric regions, even if they contained active regions (i.e., 275 12 GcFADS12, chimera G3/5/9-1, and chimera Al M1/9-2/3), their conversion rates were unstable with a change in 276 induction temperature, pH, or time (Figure 5) . Based on these results, we knew that two key allosteric and active 277 domains stabilize FADS12 properties. 278
Discussion 279
The present study indicates that FADS12 cytoplasmic regions extending from the end of the second 280 transmembrane domain to the beginning of the third transmembrane domain (section 3), the end of the third 281 transmembrane domain to the 18th amino acid of section 5 (section 5-1), and the end of the sixth transmembrane 282 domain to the 30th amino acid of section 9 (section 9-1) critically mediates FADS12 catalytic activity (Figure 1) . In 283 these three small regions, 10 sites (His112, Ser118, His156, Gln161, Lys 301, Arg306, Glu307, Ala 309, Gln313 and 284 Ser323) in MaFADS12 and 10 sites (Lys123, Ala129, Asn167, Met172, Thr302, Asp307, Ile308, Glu310, Ala314 and 285 Asp324) in GcFADS12 were identified as key sites affecting FADS12 catalytic activity. From the results of molecular 286 docking experiments with these sites and the substrate, we learned that all key sites were close to the substrate, and, in 287 the enzyme pocket, these sites associated with the substrates by van der Waals and conventional hydrogen bonds to 288 form a stable structure (Figure 6a) . The results of molecular docking experiments were in full agreement with the 289 observed FADS12 conversion rates of FADS12 (Figure 6b) . 290
The conversion rate of chimera G3/5/9-1, constructed by superimposition of three small active domains (sections 291 3, 5-1, and 9-1), reached 56.3 ± 2.3%, which was 30% lower than that of wild-type MaFADS12. We speculated that 292 this was due to feedback inhibition by the product. To exclude the effect of products on the conversion rate, 293 12,13-cyclopropenoid fatty acid was used as a product analogue; this confirmed that 12,13-cyclopropenoid fatty acid 294 inhibited GcFADS12 activity, but had no significant effect on MaFADS12 activity. There are likely allosteric regions in 295
MaFADS12 that are less sensitive to the product, whereas this allosteric region in GcFADS12 is highly sensitive to it. 296
In addition, the minimal steric hindrance of OA and maximal steric hindrance of LA and 12,13-cyclopropenoid fatty 297 acid in various twisted structures were analyzed, and diameters at which the said hindrance may interfere were 5.91Å, 298 7.21Å, and 6.72Å respectively (Figure 6c) . By comparing the pocket size of the active region of FADS12 with the 299 13 steric hindrance distance of the product or its analogues, we inferred that it was difficult for LA to be released from the 300 pocket due to steric hindrance after the catalysis of the OA substrate and feedback inhibition by the product (Figure  301   6d) . 302
Allosteric regions were again found to be located in chimeras M3/5/9-1 and G3/5/9-1 after domain swapping. The 303 results of this study showed that the activities of chimeras Al G1 and Al G9-2/3, both of which were derived from 304 chimera G3/5/9-1 by exchanging the first and last regions, respectively, were close to those of wild-type MaFADS12; 305 and the activity of chimera Al G1/9-2/3, which was derived by exchanging the first and last regions, was similar to that 306 of wild-type MaFADS12 (Figure 4a) . Based on the simulated structure of MaFADS12, these two segments can be 307 considered "flexible regions," which change during the catalytic reaction to release the product (Figure 6d ). In these 308 two regions, once an amino acid with a benzene ring structure was mutated in GcFADS12, its activity significantly 309 increased, whereas activity in the corresponding site of MaFADS12 significantly decreased (Figure 4b, c) . From the 310 docking results, we inferred that macromolecule groups such as a benzene ring at the first and last regions in FADS12 311 hindered product release (Figure 6e) . 312
The substrate conversion rate is determined by both active and allosteric regions. With changes in the induction 313 temperature, pH, or time, the substrate conversion rates of recombinant FADS12 containing a "flexible region" (i.e., 314
MaFADS12, chimera M3/5/9-1, and chimera Al G1/9-2/3) showed few significant changes, indicating that the flexible 315 region plays a role in product release, even when the overall three-dimensional structure of the enzyme changed with 316 external conditions. However, the conversion rate of chimera G3/5/9-1 with an active region but no allosteric region 317 was not stable under different conditions, suggesting that this flexible region is the key domain to maintaining FADS12 318 stability (Figure 5) . Here, the three-dimensional structure of the two regions could be analyzed by X-ray diffraction in 319 the future, which will help elucidate how the two regions combine with the substrate. 320
Conclusions 321
The present study elucidated the molecular mechanism underlying the catalytic activity of FADS12 from M. 322 alpina and G. candidum. A catalytic product of FADS12 was shown to be an inhibitor of FADS12 catabolism; also, for 323 14 the first time, a product analogue as found to inhibit this enzyme. The molecular mechanism underlying FADS12 324 inhibitory activity was analyzed based on the presence of allosteric domains and amino acid sites affecting FADS12 325 catalytic activity. These studies indicated that both allosteric and active domains can stabilize FADS12 in various 326 induction conditions. This study provides a theoretical basis for improving essential fatty acid contents in dominant 327 strains in fermented cheese. GcFADS12 (e6), chimera G3 (e7), chimera G5 (e8), chimera G9 (e9) and chimera G3/5/9-1 (e10). (f): Gas 484 chromatogram of fatty acids for the conversion rate of chimera M9-1 (f1) and chimera G9-1 (f2). 485
486

Figure 2
Relative substrate conversion efficiencies of each mutant from section 3, 5-1 and 9-1. The mutants (red 487 words under red column) of H112K, Q117G, S118A, H156N, M157L, T158Q, K159R, Q161M T298S, K301T, R306D, 488 E307I, G308T, A309E, Q313A, L317A/C318A, V320I and S323D from MaFADS12 were corresponding to the 489 mutants (blue words under blue column) of K123H, G128Q, A129S, N167H, L168M, Q169T, R170K, M172Q, S299T, 490 T302K, D307R, I308E, T309G, E310A, A314Q, A318L/A319C, I321V and D324S from GcFADS12, respectively. 491
Substrate conversion efficiency of each mutant was classified into two groups: *, conversion rate of mutant from 492 MaFADS12 > mutant from GcFADS12; ***, conversion rate of mutant from MaFADS12 < mutant from GcFADS12. constructed by reciprocal section swapping was exhibited below each FADS12 chimera name. Substrate conversion 508 efficiency of each chimera was classified into two groups: *, conversion rate of chimera M3/5/9-1 and chimera 509 G3/5/9-1; ***, conversion rate of chimera Al MX < chimera M3/5/9-1 and chimera Al GX > chimera G3/5/9-1 510 chimera GX. (b) and (c): Relative substrate conversion efficiency of each mutant from chimera M3/5/9-1 and chimera 511 G3/5/9-1, determined by adding LA substrate. The mutants (red words under red column) of Q34V, L35V, E37Q, 512 R44L, E45D, C46A, H50E, F52Y, E53K, G56Y, L57V, R58K, G59S, L60F, G334D, V336I, H337E, A341L, L344F, 513 F345V, Q347R, G10F, Q13Y, S24Y, K326F and L344F from chimera M3/5/9-1 were corresponding to the mutants 514 (blue words under blue column) of V44Q, V45L, Q47E, L54R, D55E, A56C, E60H, Y62F, K63E, Y66G, V67L, K68R, 515 S69G, F70L, D335G, I337V, E338H, L342A, F345L, V346F, R348Q, Y4A, F20G, Y23Q, Y34S, F327K, F345L and 516 F398A from chimera G3/5/9-1, respectively. Substrate conversion efficiency of each mutant was classified into two 517 groups: *, conversion rate of chimera M3/5/9-1 and chimera G3/5/9-1; ***, conversion rate of mutants from chimera 518 M3/5/9-1 < chimera M3/5/9-1 and mutants from chimera G3/5/9-1 > chimera G3/5/9-1. 519 20 520
Figure 5
Relative substrate conversion efficiencies of chimera M3/5/9-1, chimera G3/5/9-1, chimera Al M1/9-2/3, 521 chimera Al G1/9-2/3, MaFADS12 and GcFADS12 at various induced temperature (a), pH (b) and induced time (c). 522
Active domain and Allosteric domain in chimera M3/5/9-1, chimera G3/5/9-1, chimera Al M1/9-2/3, chimera Al 523 G1/9-2/3, MaFADS12 and GcFADS12 indicated with "+", none with "-". {   K123H  G128Q  A129S  H156N  M157L  T158Q  N167H  L168M  Q169T  K159R  Q161M  R170K  M172Q   E307I  G308T  A309E  I308E  T309G  E310A  Q313A  L317A/  C318A  V320I  A314Q  A318L/  A319C  I321V  S323D  D324S  T298S  K301T  R306D  S299T T302K D307R MaFADS12 GcFADS12 MaFADS12 GcFADS12
MaFADS 12 GcFADS 12 chimera G3/5/9-1 chimera M3/5/9-1 chimera M1/9-2 3 Al chimera G1 9-2/3 Al
MaFADS 12
GcFADS 12 
